|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls000761021 |
| 003 |
SK-MaSNL |
| 005 |
20260501054907.0 |
| 008 |
140402c2000 xo 0 slo |
| 015 |
|
|
|a SNBRB2001/06-19828
|
| 035 |
|
|
|a CLN000112808
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a slo
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.13/.14-074:616.151.5
|2 1997
|
| 080 |
|
|
|a 616.151.5
|2 1997
|
| 245 |
0 |
0 |
|a Vyšetrovanie diabetickej endotelopatie pomocou molekulových markerov
|c P. Galajda ... [et al.]
|
| 650 |
0 |
7 |
|a endotelopatia diabetická
|x markery molekulové
|2 snkbucl
|9 1505923
|
| 650 |
0 |
7 |
|a faktor von Willebrandov
|2 snkbucl
|9 857202
|
| 650 |
0 |
7 |
|a trombomodulín
|2 snkbucl
|9 1505924
|
| 650 |
0 |
7 |
|a dietoterapia
|2 snkbucl
|a Diabetes mellitus
|9 844265
|
| 650 |
0 |
7 |
|a endotel cievny
|x patofyziológia
|2 snkbucl
|9 1211188
|
| 650 |
0 |
7 |
|a abstrakty z kongresu
|2 snkbucl
|9 168204
|
| 650 |
0 |
7 |
|a diabetes mellitus, inzulín independentný
|x komplikácie
|2 snkbucl
|9 1309882
|
| 650 |
0 |
7 |
|a trombomodulín
|x chémia
|2 snkbucl
|9 1505925
|
| 650 |
0 |
7 |
|a von Willebrandov faktor
|x chémia
|2 snkbucl
|9 1505926
|
| 650 |
0 |
7 |
|a biologické markery
|2 snkbucl
|9 84323
|
| 650 |
0 |
7 |
|a diabetické angiopatie
|2 snkbucl
|9 19504
|
| 650 |
0 |
7 |
|a endotel cievny
|x patofyziológia
|x sekrécia
|2 snkbucl
|9 1505927
|
| 655 |
|
7 |
|a články z novín a časopisov
|2 snkbucl
|9 267496
|
| 700 |
1 |
|
|a Galajda, Peter,
|d 1960-
|4 aut
|9 195289
|
| 700 |
1 |
|
|a Blann, A.
|4 aut
|9 1505928
|
| 700 |
1 |
|
|a Kubisz, Peter,
|d 1942-2022
|4 aut
|9 192814
|
| 700 |
1 |
|
|a Mokáň, Marián,
|d 1957-
|4 aut
|9 106742
|
| 773 |
0 |
|
|t Ateroskleróza
|g Roč. 4, č. 3 (2000), s. 158
|x 1335-2253
|
| 850 |
|
|
|a Slovenská národná knižnica v Martine
|
| 852 |
|
|
|a SNK
|b KIS3GCP
|
| 958 |
|
|
|a MI
|
| 992 |
|
|
|a RBX
|
| 999 |
|
|
|c 3009232
|d 3011162
|
